Stock Code: 000553 (200553) Stock Abbreviation: ADAMA A(B) Announcement No. 2023-25 III. Company Participants Mr. Steve Hawkins, President and CEO of the Company; Ms. Efrat Nagar, the CFO; Mr. Elad Shabtai, EVP Global Operations; Mr. Guo Zhi, Board Secretary and Ms. Rivka Neufeld, Global Head of Investor Relations will attend the meeting. ADAMA Ltd. Announcement on 2023 Half-Year Performance Online Roadshow The Company and all members of the Company's Board of Directors confirm that all information disclose ...

Financial Performance - The company's revenue for Q1 2023 was 8,610,576 thousand RMB, a decrease of 4.50% compared to the same period last year[7]. - Net profit attributable to shareholders was 83,273 thousand RMB, down 80.53% year-on-year[7]. - The net cash flow from operating activities was (2,905,168) thousand RMB, a decline of 60.17% compared to the previous year[7]. - The company experienced a significant decline in profit before tax, which was 71,111 thousand RMB, down 84.34% year-on-year[11]. - The first quarter gross profit decreased year-on-year primarily due to sales decline, unfavorable exchange rates, and high-cost inventory[20]. - The total profit for Q1 2023 was CNY 71,111, a decline of 84.3% compared to CNY 453,987 in Q1 2022[34]. - The company reported a net cash flow from operating activities of CNY (2,905,168), worsening from CNY (1,813,846) in Q1 2022[37]. - The company incurred interest expenses of CNY 267,287 in Q1 2023, compared to CNY 158,501 in Q1 2022, indicating a significant increase[34]. - The company’s basic earnings per share for Q1 2023 were CNY 0.036, down from CNY 0.184 in Q1 2022[34]. Sales Performance - Sales in North America decreased by 25.7% year-on-year, primarily due to adverse weather conditions and inflation impacting consumer demand[15]. - Sales in the Asia-Pacific region, including China, fell by 18.7% year-on-year, with China specifically down 23.1%[15]. - The company's sales in the fine chemicals business in China decreased year-on-year due to weak demand, intense competition, and generally lower market prices[19]. - Despite the overall sales decline in the Asia-Pacific region, the brand product sales in China grew year-on-year when calculated in local currency[19]. - The sales performance in Thailand and South Korea was strong in the first quarter, contrasting with the negative impact on sales in the Pacific region due to the waning effects of the La Niña phenomenon[19]. Assets and Liabilities - The company's total assets increased by 1.78% year-on-year, reaching 59,010,804 thousand RMB[7]. - As of March 31, 2023, the company's total current assets amount to 34,000,935 thousand yuan, an increase from 33,140,621 thousand yuan at the end of 2022[32]. - The company's total liabilities as of March 31, 2023, are 36,067,585 thousand yuan, compared to 34,855,834 thousand yuan at the end of 2022[32]. - The company's cash and cash equivalents decreased to 3,529,280 thousand yuan from 4,290,961 thousand yuan at the end of 2022[32]. - The company's total equity attributable to shareholders is 22,943,219 thousand yuan, down from 23,124,655 thousand yuan at the end of 2022[32]. - Short-term borrowings increased significantly to 6,713,822 thousand yuan from 3,342,921 thousand yuan at the end of 2022[32]. - The company reported a decrease in total non-current liabilities to 13,847,005 thousand yuan from 14,141,213 thousand yuan at the end of 2022[32]. Research and Development - The company's R&D investment increased by 3.74% year-on-year, totaling 134,902 thousand RMB[11]. - Research and development expenses for Q1 2023 were CNY 134,902, slightly up from CNY 130,037 in Q1 2022[34]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 42.965 million, including 29.721 million A-share shareholders and 13,244 B-share shareholders[29]. - The largest shareholder, Syngenta Group Co., Ltd., holds 78.47% of shares, totaling 1,828,137,961 shares[29]. - The company has no preferred shareholders as of the reporting period[30]. Financial Expenses - Financial expenses for Q1 2023 were RMB 207 million (USD 30 million), compared to a financial gain of RMB 258 million (USD 41 million) in Q1 2022[23]. - The total financial expenses net for Q1 2023 was RMB 559 million (USD 82 million), an increase from RMB 339 million (USD 53 million) in Q1 2022, primarily due to increased short-term loans and rising interest rates[24]. - Operating expenses for the first quarter amounted to RMB 65 million (USD 9.5 million), up from RMB 36 million (USD 5.7 million) in the same period last year, mainly due to non-cash items related to asset transfers[22]. Market Environment - The overall market environment was affected by global economic slowdown and cautious purchasing behavior from farmers due to high channel inventories[10]. - The company reported a total of 41,805 thousand RMB in non-recurring gains and losses for the quarter[9].

Financial Performance - In Q1 2023, the company's sales revenue was $1.259 billion, a decrease of 11% year-over-year, with a 4% decline in RMB terms and a 7% decline at constant exchange rates[11]. - Gross profit for Q1 2023 was $310 million, down 16% from $368 million in Q1 2022, resulting in a gross margin of 24.6% compared to 25.9% in the previous year[3]. - EBITDA for Q1 2023 was $166 million, an 18% decrease from $203 million in Q1 2022, with an EBITDA margin of 13.2%[5]. - The net profit for Q1 2023 was $12 million, an 82% decline from $67 million in Q1 2022, leading to a net profit margin of 1.0%[3]. - The company experienced a significant drop in EBIT, reporting $92 million in Q1 2023, down 26% from $124 million in Q1 2022, with an EBIT margin of 7.3%[3]. - Adjusted net profit for Q1 2023 was $22 million, down 70.7% from $75 million in Q1 2022, representing 1.7% of revenue[28]. - Adjusted EBITDA for Q1 2023 was $165 million, a decline of 17.9% from $201 million in Q1 2022, accounting for 13.1% of revenue[28]. - The company's net profit attributable to shareholders for Q1 2023 was $12 million, with a net profit margin of 1.0%, down from $67 million and 4.7% in the previous year[18]. - The company reported a significant increase in the average exchange rate of USD/CNY, which rose by 8.2% to 6.872 in Q1 2023 compared to 6.348 in Q1 2022[38]. - The company incurred financial expenses of $81 million in Q1 2023, up from $53 million in Q1 2022[28]. - The total adjustments to net profit amounted to $9.4 million in Q1 2023, compared to $7.7 million in Q1 2022, reflecting a 22.1% increase[35]. - The EBITDA adjustments totaled $(0.5) million in Q1 2023, compared to $(2.4) million in Q1 2022, indicating an improvement in operational efficiency[35]. - The net profit attributable to shareholders was adjusted to $12.2 million in Q1 2023, down from $67.3 million in Q1 2022, marking a decline of 81.9%[35]. Sales Performance - The company reported a 23% decline in sales in the China market, with revenue of $182 million in Q1 2023 compared to $237 million in Q1 2022[12]. - The North American region saw a 26% decrease in sales, with revenue of $211 million in Q1 2023 compared to $284 million in Q1 2022[12]. - Sales in the crop protection products segment for Q1 2023 were $1.146 billion, accounting for 91.1% of total sales, down from $1.271 billion in Q1 2022[20]. - The company's sales of herbicides in Q1 2023 were $575 million, representing 45.7% of total sales, a decrease from $659 million and 46.4% in the same period last year[22]. - In Q1 2023, the company's sales in Europe, Africa, and the Middle East increased, particularly in the UK and Germany, despite challenges such as high channel inventory and adverse weather conditions[13]. - North American sales decreased year-over-year due to unfavorable weather and inflation impacting consumer demand, with agricultural sales also declining due to high channel inventory[13]. - In Latin America, Brazil saw a slight increase in sales, while other countries like Argentina and Ecuador experienced declines due to adverse weather conditions[13]. Operational Insights - The company launched 16 new differentiated products in Q1 2023, including insecticides and herbicides based on proprietary technologies[9]. - The company anticipates improved product demand as inventory levels are expected to decrease during the busy agricultural season in Latin America and India[3]. - The company is focusing on expanding its product line through its "Formulation Wins" strategy, which includes the development of new proprietary formulation technologies[9]. - The company expects continued improvements in operational performance as the facility upgrades in China are completed, leading to a recovery in production capacity[37]. Cash Flow and Working Capital - As of March 31, 2023, working capital increased to $3.148 billion from $2.695 billion year-over-year, primarily due to higher inventory levels[19]. - The first quarter saw a cash flow consumption of $423 million from operating activities, compared to $286 million in the same period last year, reflecting typical seasonal characteristics[19]. - Cash flow from operating activities for Q1 2023 was $(425) million, worsening from $(286) million in Q1 2022[31]. - Free cash flow for Q1 2023 was $(542) million, compared to $(386) million in Q1 2022[31]. - The company plans to continue investing in new fixed and intangible assets, with cash outflows of $85 million for Q1 2023[31]. Balance Sheet Highlights - Total assets as of March 31, 2023, were $8,588 million, an increase from $8,441 million as of March 31, 2022[29]. - Total liabilities as of March 31, 2023, were $5,249 million, compared to $5,078 million as of March 31, 2022[29]. - The company reported a total equity of $3,339 million as of March 31, 2023, slightly down from $3,364 million as of March 31, 2022[29].

Stock Code: 000553 (200553) Stock Abbreviation: ADAMA A(B) Announcement No. 2023-8 ADAMA Ltd. Announcement on 2022 Full-Year Performance Online Roadshow The Company and all members of the Company's Board of Directors confirm that all information disclosed herein is true, accurate and complete, with no false or misleading statement or material omission. I. General Information and Meeting Time ADAMA Ltd. (hereinafter referred to as "the Company") plans to announce 2022 Annual Report on March 21st , 2023 (Tues ...

安道麦股份有限公司 2022 年第三季度报告 证券代码：000553（200553） 证券简称：安道麦 A（B） 公告编号：2022-29 号 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 安道麦股份有限公司 2022 年第三季度报告 作为全球植保行业的领军企业，安道麦股份有限公司（以下简称"公司"）为世界各地的农民提供 除草、杀虫及杀菌解决方案。安道麦是全球拥有最广泛且多元化原药产品的企业之一，研发实力雄厚， 生产设施与制剂工艺走在世界前列；在企业文化上倡导赋权增能，鼓励活跃在各个市场前沿的安道麦 人倾心听取农民意见，在田间激发创想。安道麦凭借于此奠定了独特的市场定位，以丰富、独特的复 配品种和制剂技术、以及高质量的差异化产品为基础，将解决方案交付给全球 100 多个国家的农民和 客户，满足他们的多样需求。 更多重点信息及详细内容请参见报告附件。 2022 年 10 月 1 安道麦股份有限公司 2022 年第三季度报告 重要内容提示: 1. 公司董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏， ...

安道麦发布 2022 年第三季度及前九个月财务业绩 巴西一马当先，全球销售价格与销量继续保持上行 驱动第三季度与前九个月销售额实现增长 2022 年第三季度业绩概要 2022 年前九个月业绩概要 中国北京及以色列特拉维夫，2022 年 10 月 26 日——安道麦股份有限公司（以下简称"公司"，深 证 000553）于今日发布截至 2022 年 9 月 30 日的第三季度及前九个月财务业绩。 安道麦总裁兼首席执行官多明阁（Ignacio Dominguez）就业绩表示："公司今年第三季度的销售 额在巴西业务的带动下再次表现强劲，反映了植保产品的市场需求坚挺，农民保持着盈利。在经济基 本面的有力支撑之下，大宗农产品价格预计将保持历史高位，继续支撑市场对植保产品的需求。 当前市场挑战重重，但安道麦矢志不渝地为世界各地的农民服务。我们看到极端天气条件与全球 大宗农产品贸易失序对粮食安全造成了与日俱增的压力。越是在不确定因素影响加剧的时期，植保行 业对于帮助农民提升收成的宝贵作用越发凸显。安道麦将一如既往，坚定不移地支持农民保障世界粮 食供应。" 1 在价格上涨 18%和销量提高 6%的带动下，销售额同比增长 18% ...

安道麦股份有限公司 2022 年半年度报告全文 安道麦股份有限公司 2022 年半年度报告 作为全球植保行业的领军企业，安道麦股份有限公司为世界各地的农民提供除草、杀虫及杀菌 解决方案。安道麦是全球拥有最广泛且多元化原药产品的企业之一，研发实力雄厚，生产设施与制 剂工艺走在世界前列；在企业文化上倡导赋权增能，鼓励活跃在各个市场前沿的安道麦人倾心听取 农民意见，在田间激发创想。安道麦凭借于此奠定了独特的市场定位，以丰富、独特的复配品种和 制剂技术、以及高质量的差异化产品为基础，将解决方案交付给全球 100多个国家的农民和客户，满 足他们的多样需求。 更多重点信息及详细内容请参见报告附件。 2022 年 8 月 1 安道麦股份有限公司 2022 年半年度报告全文 第一节 重要提示、目录和释义 2 ▪ 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 ▪ 公司负责人（总裁兼首席执行官、法定代表人）Ignacio Dominguez、主管会计工作负 责人（首席财务官）及会计机构负责人 Shahar Florentz ...

更多重点信息及详细内容请参见报告附件。 安道麦股份有限公司 2022 年第一季度报告 证券代码：000553（200553） 证券简称：安道麦 A（B） 公告编号：2022-18 号 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 安道麦股份有限公司 2022 年第一季度报告 作为全球植保行业的领军企业，安道麦股份有限公司（以下简称"公司"）为世界各地的农民提供 除草、杀虫及杀菌解决方案。安道麦是全球拥有最广泛且多元化原药产品的企业之一，研发实力雄厚， 生产设施与制剂工艺走在世界前列；在企业文化上倡导赋权增能，鼓励活跃在各个市场前沿的安道麦 人倾心听取农民意见，在田间激发创想。安道麦凭借于此奠定了独特的市场定位，以丰富、独特的复 配品种和制剂技术、以及高质量的差异化产品为基础，将解决方案交付给全球 100 多个国家的农民和 客户，满足他们的多样需求。 2022 年 4 月 1 安道麦股份有限公司 2022 年第一季度报告 重要内容提示: 1. 公司董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并 ...

安道麦股份有限公司 2021 年年度报告全文 安道麦股份有限公司 2021 年年度报告 作为全球植保行业的领军企业，安道麦股份有限公司为世界各地的农民提供除草、杀虫及杀菌解 决方案。安道麦是全球拥有最广泛且多元化原药产品的企业之一，研发实力雄厚，生产设施与制剂工 艺走在世界前列；在企业文化上倡导赋权增能，鼓励活跃在各个市场前沿的安道麦人倾心听取农民意 见，在田间激发创想。安道麦凭借于此奠定了独特的市场定位，以丰富、独特的复配品种和制剂技术、 以及高质量的差异化产品为基础，将解决方案交付给全球 100 多个国家的农民和客户，满足他们的多 样需求。 更多重要信息及详细内容请参见报告附件。 2022 年 3 月 1 安道麦股份有限公司 2021 年年度报告全文 第一节 重要提示、目录和释义 2 ▪ 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 ▪ 公司负责人（总裁兼首席执行官）兼法定代表人、主管会计工作负责人（代行首席财 务官）及会计机构负责人 Ignacio Dominguez 声明：保证年度报告中财务报告的真 ...

安道麦公布 2021 年三季度及前九个月财务业绩 销量持续有力提升，驱动三季度及前九个月销售额强劲增长 因利润率持续承压利润受到影响 2021 年三季度财务业绩要点 2021 年前九个月财务业绩要点 中国北京及以色列特拉维夫，2021 年 10 月 27 日 —— 安道麦股份有限公司（以下简称"公司"， 深证 000553）于今日发布截至 2021 年 9 月 30 日的第三季度及前九个月财务业绩。 安道麦总裁兼首席执行官多明阁（Ignacio Dominguez）表示："第三季度对安道麦、乃至整个植 保行业来说都充满挑战。尽管在作物价格持续上涨、农民对产品需求强劲的带动下，公司销售额继续 强劲增长，但成本与供应遭遇严重挑战。全球物流与供应依旧阻滞，加剧了许多关键产品本已紧张的 供应态势，导致原材料与中间体的采购成本进一步攀升。由于全球市场竞争激烈，致使增加的成本难 以快速传导为价格提升，市场供需不平衡继续对公司利润率造成压力。尽管面临种种挑战，安道麦仍 然实现了持续增长，上调产品价格，改善产品组合与业务质量，严控各项费用，克服当前市场形势的 动荡不定继续向前发展。" 1 在销量同比有力增长 14%的驱动之下 ...